Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

Latest investments Show all
$210,000,000
Venture capital (Series B)
Umoja Biopharma
$150,000,000
Venture capital (Series B)
Visen Pharmaceuticals
Team Size
1–10
Employees
Geographical Focus
Past year's investments
  • 4 rounds in the past year
  • $520M deployed in total
  • $130M avg per round
Latest rounds
  • Umoja Biopharma: Venture capital (Series B) ($210M)
  • Visen Pharmaceuticals: Venture capital (Series B) ($150M)
  • Galecto, Inc.: Undisclosed ($64M)